August 6, 2024
WEST HILLS, Calif. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) for use as a companion diagnostic with TECELRA® (afamitresgene autoleucel), Adaptimmune’s newly approved T-cell receptor (TCR) therapy for the [...]
August 6, 2024
Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral vectors in cell and gene therapy Rebrand follows Series A funding round in February 2024 Bedfordshire, UK: MIP Discovery today announced the Company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the [...]
August 6, 2024
BOSTON, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced a significant minority investment in BioGlyph, a startup biotech software company that is developing technology to visually illustrate, register, and model biologic molecules including, specifically, multispecific antibodies (MsAbs). BioGlyph possesses proprietary technology and exceptional talent in the realm of [...]
August 6, 2024
BioFlyte’s BioTOF z200 allows SoBran to screen all types of mail for airborne biological and chemical threats like fentanyl in one device to lower operational costs and processing time while simultaneously expanding the number of agents that can be accurately identified. ALBUQUERQUE, N.M. — BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class [...]
Seqera acquires tinybio to Advance Science for Everyone – Now Through GenAI!
August 6, 2024
We are thrilled to announce that Seqera is joining forces with tinybio, a NYC-based tech-bio start-up known for its AI-integrated scientific tools focused on executing pipelines and analyses via natural language. We are happy to welcome the tinybio team and community into the Seqera family. Empowering All Scientists with Advanced Data Tools Scientists spend a significant proportion [...]
August 6, 2024
San Dimas, CA — CRAIC Technologies, a leading provider of scientific instrumentation, is proud to unveil FilmPro 2™, an advanced software solution designed to revolutionize thin film thickness measurements for researchers and industry professionals. Thin films play a crucial role in numerous industries, including semiconductor manufacturing, optical coatings, and surface engineering. Accurate measurement of thin [...]
August 6, 2024
Assay Automation Makes Cutting-Edge Research More Accessible to Labs INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight™ Oncology 500 DNA/RNA assay [...]
Sysmex Expands Strategic Alliance Agreement with QIAGEN in the Field of Genetic Testing
August 6, 2024
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today that it has expanded its strategic Alliance Agreement with QIAGEN N.V. (HQ: Venlo, The Netherlands; CEO: Thierry Bernard) to deepen their collaboration in genetic testing, including research and development, production, clinical development, and sales-marketing. Sysmex and QIAGEN have built a successful partnership since the initial [...]
SPECS-TII Inc. and Nanosurf Join Forces
August 5, 2024
SPECS-TII Inc. is excited to announce that as of August 1, 2024, the distribution, support, and application services of Nanosurf AG in the United States will be integrated into our business. SPECS-TII Inc. is a subsidiary of SPECS Surface Nano Analysis GmbH in Germany, which together with Nanosurf AG forms the Advanced Metrology and Microscopy [...]
August 5, 2024
PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today its involvement in TenK10K, a large-scale, multi-year study led by the Garvan Institute of Medical Research. The TenK10K project intends to map 50 million human cells from 10,000 people to identify unique genomic fingerprints of autoimmune diseases, [...]

